Selective IL-2 responsiveness of regulatory T Cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes

A. Yu, I. Snowhite, F. Vendrame, M. Rosenzwajg, D. Klatzman, Alberto Pugliese, Thomas Malek

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)S73
JournalDiabetes Technology and Therapeutics
Volume18
DOIs
StatePublished - Feb 1 2016

Fingerprint

Regulatory T-Lymphocytes
Type 1 Diabetes Mellitus
Interleukin-2
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Selective IL-2 responsiveness of regulatory T Cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. / Yu, A.; Snowhite, I.; Vendrame, F.; Rosenzwajg, M.; Klatzman, D.; Pugliese, Alberto; Malek, Thomas.

In: Diabetes Technology and Therapeutics, Vol. 18, 01.02.2016, p. S73.

Research output: Contribution to journalArticle

@article{c1bfcf913bb946d6a0160431b5e6da05,
title = "Selective IL-2 responsiveness of regulatory T Cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes",
author = "A. Yu and I. Snowhite and F. Vendrame and M. Rosenzwajg and D. Klatzman and Alberto Pugliese and Thomas Malek",
year = "2016",
month = "2",
day = "1",
doi = "10.1089/dia.2016.2507",
language = "English (US)",
volume = "18",
pages = "S73",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",

}

TY - JOUR

T1 - Selective IL-2 responsiveness of regulatory T Cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes

AU - Yu, A.

AU - Snowhite, I.

AU - Vendrame, F.

AU - Rosenzwajg, M.

AU - Klatzman, D.

AU - Pugliese, Alberto

AU - Malek, Thomas

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84957628953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957628953&partnerID=8YFLogxK

U2 - 10.1089/dia.2016.2507

DO - 10.1089/dia.2016.2507

M3 - Article

AN - SCOPUS:84957628953

VL - 18

SP - S73

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

ER -